Update: Candel Therapeutics Prices $80 Million Public Offering -- Shares Fall

MT Newswires Live2024-12-14

(Updates with the latest stock move in the first paragraph and the headline.)

Candel Therapeutics (CADL) shares were down more than 30% in recent Friday trading, a day after the company said it priced a public offering of 10 million shares at $6 apiece and pre-funded warrants for about 3.3 million shares at $5.99 per warrant to raise about $80 million in gross proceeds.

Underwriters have been granted a 30-day option to purchase up to an additional 2 million shares.

Net proceeds from the offering, which is expected to close around Dec. 16, will be used to continue the development of the company's product candidates and for general corporate purposes.

Price: 6.85, Change: -2.95, Percent Change: -30.10

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment